Cargando…

Benefits of newborn screening and hematopoietic cell transplant in infantile Krabbe disease

Infantile Krabbe disease (IKD) can be treated with hematopoietic cell transplantation (HCT) if done during the first weeks of life before symptoms develop. To facilitate this, newborn screening (NBS) has been instituted in 8 US states. An application to add IKD to the recommended NBS panel is curren...

Descripción completa

Detalles Bibliográficos
Autores principales:	Page, Kristin M., Ream, Margie A., Rangarajan, Hemalatha G., Galindo, Rafael, Mian, Ali Y., Ho, Mai-Lan, Provenzale, James, Gustafson, Kathryn E., Rubin, Jennifer, Shenoy, Shalini, Kurtzberg, Joanne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2022
Materias:	Transplantation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092415/ https://www.ncbi.nlm.nih.gov/pubmed/35042231 http://dx.doi.org/10.1182/bloodadvances.2021006094

Ejemplares similares

Consensus guidelines for newborn screening, diagnosis and treatment of infantile Krabbe disease
por: Kwon, Jennifer M., et al.
Publicado: (2018)

Optic nerve enlargement in infantile form of Krabbe disease
por: Castilha-Neto, Dimas, et al.
Publicado: (2012)

Survey of quality of life, phenotypic expression, and response to treatment in Krabbe leukodystrophy
por: Langan, Thomas J., et al.
Publicado: (2019)

Report of a Case that Expands the Phenotype of Infantile Krabbe Disease
por: Nashabat, Marwan, et al.
Publicado: (2019)

Prognostic Value of Hematogones in Patients With Hematopoietic Disorders After Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis
por: Mori, Hirotaka, et al.
Publicado: (2023)

Impact of cryopreservation and transit times of allogeneic grafts on hematopoietic and immune reconstitution
por: Maurer, Katie, et al.
Publicado: (2021)

Genetic associations with immune-mediated outcomes after allogeneic hematopoietic cell transplantation
por: Martin, Paul J., et al.
Publicado: (2022)

Allogeneic T cells cause acute renal injury after hematopoietic cell transplantation
por: Miyata, Masahiro, et al.
Publicado: (2023)

Graft rejection markers in children undergoing hematopoietic cell transplant for bone marrow failure
por: Sabulski, Anthony, et al.
Publicado: (2021)

Variables affecting outcomes after allogeneic hematopoietic stem cell transplant for cerebral adrenoleukodystrophy
por: Chiesa, Robert, et al.
Publicado: (2022)

Cardiac toxicity after matched allogeneic hematopoietic cell transplant in the posttransplant cyclophosphamide era
por: Yeh, Jason, et al.
Publicado: (2021)

Antithymocyte globulin exposure in CD34(+) T-cell–depleted allogeneic hematopoietic cell transplantation
por: Lakkaraja, Madhavi, et al.
Publicado: (2022)

Long-term patient-reported neurocognitive outcomes in adult survivors of hematopoietic cell transplant
por: Wu, Natalie L., et al.
Publicado: (2022)

Outcomes of allogeneic hematopoietic cell transplantation in adults with fusions associated with Ph-like ALL
por: Aldoss, Ibrahim, et al.
Publicado: (2022)

Abatacept GVHD prophylaxis in unrelated hematopoietic cell transplantation for pediatric bone marrow failure
por: Stenger, Elizabeth O., et al.
Publicado: (2023)

Eltrombopag for the Treatment of Allogeneic Hematopoietic Stem Cell Transplantation-Related Poor Graft Function
por: Arslan Davulcu, Eren, et al.
Publicado: (2023)

Next-generation sequencing–based MRD in adults with ALL undergoing hematopoietic cell transplantation
por: Liang, Emily C., et al.
Publicado: (2023)

Unfavorable transcriptome profiles and social disadvantage in hematopoietic cell transplantation: a CIBMTR analysis
por: Taylor, Mallory R., et al.
Publicado: (2023)

Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma
por: Herrera, Alex F., et al.
Publicado: (2021)

Improvements in allogeneic hematopoietic cell transplantation outcomes for adults with ALL over the past 3 decades
por: Nishiwaki, Satoshi, et al.
Publicado: (2022)

Respiratory viruses in hematopoietic cell transplant candidates: impact of preexisting lower tract disease on outcomes
por: Kim, Yae-Jean, et al.
Publicado: (2022)

Role of NKG2D ligands and receptor in haploidentical related donor hematopoietic cell transplantation
por: Petersdorf, Effie W., et al.
Publicado: (2023)

Incidence, risk factors, and impact of early cardiac toxicity after allogeneic hematopoietic cell transplant
por: Pérez-Valencia, Amanda Isabel, et al.
Publicado: (2022)

Clinical impact of cryopreservation of allogeneic hematopoietic cell grafts during the onset of the COVID-19 pandemic
por: Devine, Steven M., et al.
Publicado: (2023)

Ultrasensitive chimerism enhances measurable residual disease testing after allogeneic hematopoietic cell transplantation
por: Kanaan, Sami B., et al.
Publicado: (2023)

Human herpesvirus 6–specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipients
por: Noviello, Maddalena, et al.
Publicado: (2023)

Selected memory T cells infused post–haploidentical hematopoietic stem cell transplantation persist and hyperexpand
por: van Beek, Jasper J. P., et al.
Publicado: (2022)

Allogeneic hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a CIBMTR analysis
por: Murthy, Hemant S., et al.
Publicado: (2023)

Risk factors for seasonal human coronavirus lower respiratory tract infection after hematopoietic cell transplantation
por: Ogimi, Chikara, et al.
Publicado: (2021)

Predicting mortality from intracranial hemorrhage in patients who undergo allogeneic hematopoietic stem cell transplantation
por: Ren, Xiying, et al.
Publicado: (2021)

Gut microbiota diversity before allogeneic hematopoietic stem cell transplantation as a predictor of mortality in children
por: Masetti, Riccardo, et al.
Publicado: (2023)

Circulating microbial cell–free DNA is increased during neutropenia after hematopoietic stem cell transplantation
por: Blair, Lily M., et al.
Publicado: (2023)

Neuroradiological, neurophysiological and molecular findings in infantile Krabbe disease: two case reports
por: Vargiami, E, et al.
Publicado: (2016)

Activation of the zinc-sensing receptor GPR39 promotes T-cell reconstitution after hematopoietic cell transplant in mice
por: Iovino, Lorenzo, et al.
Publicado: (2022)

The promising efficacy of a risk-based letermovir use strategy in CMV-positive allogeneic hematopoietic cell recipients
por: Sourisseau, Mathilde, et al.
Publicado: (2022)

COVID-19 and hematopoietic stem cell transplantation and immune effector cell therapy: a US cancer center experience
por: Maurer, Katie, et al.
Publicado: (2021)

The day 100 score predicts moderate to severe cGVHD, transplant mortality, and survival after hematopoietic cell transplantation
por: Metafuni, Elisabetta, et al.
Publicado: (2022)

Graft-Versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplant: SARS-CoV-2 Vaccine as a Potential Trigger
por: Azem, Amin, et al.
Publicado: (2022)

Regional differences in fiber tractography predict neurodevelopmental outcomes in neonates with infantile Krabbe disease
por: Gupta, A., et al.
Publicado: (2014)

Haploidentical vs matched unrelated donors for patients with ALL: donor age matters more than donor type
por: Mehta, Rohtesh S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_88b4pk4ucn5fgmqr3fkeobupoh